Association between serum chloride and prevalence of metabolic syndrome in the general U.S. adult population: evidence from NHANES 2011-2018.

BMC Endocr Disord · 2025 · PMC11892319 · PMID 40059142

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a significant trendno p-value reported

In model 1, participants in the second tertile of serum chloride had a 17% lower risk of MetS (OR = 0.83, 95% CI: 0.72–0.95, p = 0.01), and those in the highest tertile had a 19% lower risk (OR = 0.81, 95% CI: 0.69–0.95, p = 0.01), with a significant trend (p for trend < 0.01).

also in 9,775 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.